Entera Appoints Ramesh Ratan as Chief Financial Officer
BOSTON and JERUSALEM, Israel, April 15, 2021 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX),…
Month: April 2021
Longeveron Announces Successful Completion of Phase I/II Clinical Study of Lomecel-B Infusion in Aging Frailty Subjects to Improve Immune Response Following Influenza Vaccination
Study intended to evaluate safety, and potential immunomodulatory effect of Lomecel-B on aging-associated decline in…
NKGen Biotech Announces Appointment of Steven Cha, MD as Chief Medical Officer
SANTA ANA, Calif., April 15, 2021 (GLOBE NEWSWIRE) — NKGen Biotech, a biotechnology company harnessing…
Chinook Therapeutics Presents Data During the ISN World Congress of Nephrology 2021
Poster presentation on BION-1301 including Gd-IgA1 biomarker data in healthy volunteers from Parts 1 and…
Adverum Files Definitive Proxy Materials and Mails Letter to Stockholders Detailing Strength of Team and Acceleration Toward Commercialization of ADVM-022
Adverum 1, 3 and 5-Year Total Stockholder Returns Adverum 1, 3 and 5-Year Total Stockholder…
Panbela Announces Partial Clinical Hold Lifted on Phase I Polyamine Metabolic Inhibitor Study in Pancreatic Cancer
MINNEAPOLIS, April 15, 2021 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
Spectral Medical Announces Exercise of Warrants for Gross Proceeds of Approximately $3.0 Million
TORONTO, April 15, 2021 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:…
Brickell Biotech Announces Publication of its HDSM-Ax Patient Reported Outcome Scale Validation Results in the Journal of Drugs in Dermatology
HDSM-Ax scale is a well-defined and reliable measure of primary axillary hyperhidrosis severity and a…
Galectin-3 has a key role in Gastric Cancer
Galecto Announces Publication of Paper in the Gastric Cancer Journal BOSTON, April 15, 2021 (GLOBE…
Revolo Biotherapeutics Enters Manufacturing Agreement with CordenPharma to Scale Up and Manufacture ‘1104 for the Treatment of Eosinophilic Esophagitis and Allergic Disease
Agreement ensures supply to support clinical and commercial operations NEW ORLEANS and LONDON, April 15,…
AltruBio Raises $63 Million Series A Round To Continue Its Company Transformation
REDWOOD CITY, Calif., April 15, 2021 (GLOBE NEWSWIRE) — AltruBio Inc. (“AltruBio” or “the Company”),…
AzurRx BioPharma CEO Issues Letter to Shareholders
DELRAY BEACH, Fla., April 15, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx”…
Trevena, Inc. Announces Presentations of OLINVYK™ Health Economic Models at AMCP 2021 Annual Meeting
— Models demonstrate substantial overall cost savings for hospitals when using OLINVYK compared to IV…
InflaRx Completes Enrollment of Vilobelimab Phase IIa Study in Pyoderma Gangraenosum
Target enrollment of 18 patients reached across three different dose groups Interim results will be…
Zynerba Pharmaceuticals Announces the Acceptance of Two Posters at the Society of Biological Psychiatry 2021 Virtual Meeting
DEVON, Pa., April 15, 2021 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader…
Teligent Announces Hiring of Chief Financial Officer
BUENA, N.J., April 15, 2021 (GLOBE NEWSWIRE) — Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”),…
Recro Expands Development and Manufacturing Relationship With Ensysce Biosciences
Additional Contract Broadens and Further Strengthens Customer Product Portfolio GAINESVILLE, Ga., April 15, 2021 (GLOBE…
COVIS PHARMA GROUP Announces Top-line Safety and Efficacy Data from a Phase 3 Placebo-Controlled COVID-19 Study Using Inhaled Corticosteroid (ciclesonide)
ZUG, Switzerland, April 15, 2021 (GLOBE NEWSWIRE) — Covis Pharma Group (the “Company”), a global…
Arch Biopartners Enters into Worldwide License Agreement with Telara Pharma to Re-Purpose Cilastatin for the Treatment and Prevention of Acute Kidney Injury
Arch Biopartners is a clinical stage company developing new drug candidates for treating organ damage…
FibroGen Receives Rare Pediatric Disease Designation from the U.S. FDA for Pamrevlumab for the Treatment of Duchenne Muscular Dystrophy
SAN FRANCISCO, April 15, 2021 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) announced that the…